Epidemiology of Neonatal Sepsis in Neonatal Intensive Care Unit in Assiut University Children Hospital
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Neonatal sepsis is an important cause of morbidity and mortality in the pediatric age group . It is one of the leading causes of death in the first 28 days of life both in the developed and developing countries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2017
CompletedFirst Posted
Study publicly available on registry
November 28, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedDecember 5, 2017
November 1, 2017
1 year
October 28, 2017
December 3, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Incidence of neonatal sepsis
by measuring the incidence of neonatal sepsis helping to know the size of the problem of neonatal sepsis
up to 4 months
prevalence of neonatal sepsis
by measuring the prevalence of neonatal sepsis this help us to manage neonatal sepsis accordingly
up to 4 months
Secondary Outcomes (1)
risk factors and causative organisms of neonatal sepsis
up to 4 months
Study Arms (2)
complete blood count
blood sample is collected from infant to detect presence of sepsis
c reactive protein
measuring c reactive protein in blood sample to determine neonatal sepsis
Interventions
blood culture to determine causative organisms of neonatal sepsis
Eligibility Criteria
All admitted male and female infant from the birth to the day 30 after birth
You may qualify if:
- All admitted inborn and out born neonates during this study period will be screened for sepsis
You may not qualify if:
- All cases that mimic neonatal sepsis such as;
- Inborn errors of metabolism
- Congestive heart failure
- Hemolytic Disease of Newborn
- Hypoxic ischemic encephalopathy
- Congenital Diaphragmatic Hernia
- Intra cranial hemorrhage
- Respiratory Distress Syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gehan Mo Kamal El_Din, Professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 28, 2017
First Posted
November 28, 2017
Study Start
January 1, 2018
Primary Completion
January 1, 2019
Study Completion
July 1, 2019
Last Updated
December 5, 2017
Record last verified: 2017-11